Senior Adult Oncology

Restricted access
  • 1

    Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277300.

  • 2

    Altekruse SF, Kosary CL, Krapcho M., eds. SEER Cancer Statistics Review, 1975–2007: National Cancer Institute. Bethesda, MD, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Available at: http://seer.cancer.gov/csr/1975_2007/. Accessed January 12, 2012.

    • Search Google Scholar
    • Export Citation
  • 3

    Smith BD, Smith GL, Hurria A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009;27:27582765.

    • Search Google Scholar
    • Export Citation
  • 4

    Balducci L, Beghe C. Cancer and age in the USA. Crit Rev Oncol Hematol 2001;37:137145.

  • 5

    Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004;22:46264631.

    • Search Google Scholar
    • Export Citation
  • 6

    Saltzstein SL, Behling CA. 5- and 10-year survival in cancer patients aged 90 and older: a study of 37,318 patients from SEER. J Surg Oncol 2002;81:113116; dicussion 117.

    • Search Google Scholar
    • Export Citation
  • 7

    Extermann M. Management issues for elderly patients with breast cancer. Curr Treat Options Oncol 2004;5:161169.

  • 8

    Chen H, Cantor A, Meyer J. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer 2003;97:11071114.

  • 9

    Christman K, Muss HB, Case LD, Stanley V. Chemotherapy of metastatic breast cancer in the elderly. The Piedmont Oncology Association experience [see comment]. JAMA 1992;268:5762.

    • Search Google Scholar
    • Export Citation
  • 10

    Sargent DJ, Goldberg RM, Jacobson SD. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001;345:10911097.

    • Search Google Scholar
    • Export Citation
  • 11

    Balducci L. Management of cancer in the elderly. Oncology (Williston Park) 2006;20:135143.

  • 12

    Wedding U, Honecker F, Bokemeyer C. Tolerance to chemotherapy in elderly patients with cancer. Cancer Control 2007;14:4456.

  • 13

    Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001;285:27502756.

  • 14

    Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006;295:801808.

    • Search Google Scholar
    • Export Citation
  • 15

    Carey EC, Walter LC, Lindquist K, Covinsky KE. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med 2004;19:10271033.

    • Search Google Scholar
    • Export Citation
  • 16

    Studenski S, Perera S, Patel K. Gait speed and survival in older adults. JAMA 2011;305:5058.

  • 17

    Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007;25:18241831.

  • 18

    Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 2010;60:120132.

    • Search Google Scholar
    • Export Citation
  • 19

    Rodin MB, Mohile SG. A practical approach to geriatric assessment in oncology. J Clin Oncol 2007;25:19361944.

  • 20

    Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000;5:224237.

  • 21

    Ingram SS, Seo PH, Martell RE. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 2002;20:770775.

    • Search Google Scholar
    • Export Citation
  • 22

    Repetto L, Fratino L, Audisio RA. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20:494502.

    • Search Google Scholar
    • Export Citation
  • 23

    Maione P, Perrone F, Gallo C. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005;23:68656872.

    • Search Google Scholar
    • Export Citation
  • 24

    Koroukian SM, Xu F, Bakaki PM. Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer. J Gerontol A Biol Sci Med Sci 2010;65:322329.

    • Search Google Scholar
    • Export Citation
  • 25

    Winkelmann N, Petersen I, Kiehntopf M. Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma. J Cancer Res Clin Oncol 2011;137:733738.

    • Search Google Scholar
    • Export Citation
  • 26

    Clough-Gorr KM, Thwin SS, Stuck AE, Silliman RA. Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment. Eur J Cancer 2011; July 7 [Epub ahead of print].

    • Search Google Scholar
    • Export Citation
  • 27

    Caillet P, Canoui-Poitrine F, Vouriot J. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA Study. J Clin Oncol 2011;29:36363642.

    • Search Google Scholar
    • Export Citation
  • 28

    Hurria A, Gupta S, Zauderer M. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 2005;104:19982005.

  • 29

    Hurria A, Mohile S, Lichtman S. Geriatric assessment of older adults with cancer: baseline data from a 500 patient multicenter study [abstract]. J Clin Oncol 2009;27(Suppl 15):Abstract 9546.

    • Search Google Scholar
    • Export Citation
  • 30

    Hurria A, Cirrincione CT, Muss HB. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 2011:12901296.

    • Search Google Scholar
    • Export Citation
  • 31

    Overcash JA, Beckstead J, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol 2005;54:129136.

    • Search Google Scholar
    • Export Citation
  • 32

    Overcash JA, Beckstead J, Moody L. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol 2006;59:205210.

    • Search Google Scholar
    • Export Citation
  • 33

    Katz S, Ford AB, Moskowitz RW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914919.

    • Search Google Scholar
    • Export Citation
  • 34

    Lawton MP. Scales to measure competence in everyday activities. Psychopharmacol Bull 1988;24:609614.

  • 35

    Freyer G, Geay JF, Touzet S. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005;16:17951800.

    • Search Google Scholar
    • Export Citation
  • 36

    Lachs MS, Feinstein AR, Cooney LM. A simple procedure for general screening for functional disability in elderly patients. Ann Intern Med 1990;112:699706.

    • Search Google Scholar
    • Export Citation
  • 37

    Saliba D, Elliott M, Rubenstein LZ. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001;49:16911699.

    • Search Google Scholar
    • Export Citation
  • 38

    Min L, Yoon W, Mariano J. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc 2009;57:20702076.

    • Search Google Scholar
    • Export Citation
  • 39

    Luciani A, Ascione G, Bertuzzi C. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010;28:20462050.

    • Search Google Scholar
    • Export Citation
  • 40

    Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003;114:180187.

    • Search Google Scholar
    • Export Citation
  • 41

    Taaffe DR, Harris TB, Ferrucci L. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci 2000;55:M709715.

    • Search Google Scholar
    • Export Citation
  • 42

    Wilson CJ, Cohen HJ, Pieper CF. Cross-linked fibrin degradation products (D-dimer), plasma cytokines, and cognitive decline in community-dwelling elderly persons. J Am Geriatr Soc 2003;51:13741381.

    • Search Google Scholar
    • Export Citation
  • 43

    Extermann M. Interaction between comorbidity and cancer. Cancer Control 2007;14:1322.

  • 44

    Pal SK, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 2010;28:40864093.

  • 45

    Nanda A, Chen MH, Braccioforte MH. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA 2009;302:866873.

    • Search Google Scholar
    • Export Citation
  • 46

    Meyerhardt JA, Catalano PJ, Haller DG. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003;21:433440.

  • 47

    Srokowski TP, Fang S, Hortobagyi GN, Giordano SH. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 2009;27:21702176.

    • Search Google Scholar
    • Export Citation
  • 48

    Piccirillo JF, Tierney RM, Costas I. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:24412447.

  • 49

    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373383.

    • Search Google Scholar
    • Export Citation
  • 50

    Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622626.

  • 51

    Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 1981;36:428434.

    • Search Google Scholar
    • Export Citation
  • 52

    Breccia M, Latagliata R, Stagno F. Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib. Haematologica 2011;96:14571461.

    • Search Google Scholar
    • Export Citation
  • 53

    Sanabria A, Carvalho AL, Melo RL. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008;30:170177.

    • Search Google Scholar
    • Export Citation
  • 54

    Frasci G, Lorusso V, Panza N. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000;18:25292536.

    • Search Google Scholar
    • Export Citation
  • 55

    Hurria A, Brogan K, Panageas KS. Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 2005;92:151156.

    • Search Google Scholar
    • Export Citation
  • 56

    Fader AN, von Gruenigen V, Gibbons H. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecol Oncol 2008;109:3338.

    • Search Google Scholar
    • Export Citation
  • 57

    Gronberg BH, Sundstrom S, Kaasa S. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer 2010;46:22252234.

    • Search Google Scholar
    • Export Citation
  • 58

    Ngeow J, Leong SS, Gao F. Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance status. Crit Rev Oncol Hematol 2010;76:5360.

    • Search Google Scholar
    • Export Citation
  • 59

    Sanabria A, Carvalho AL, Vartanian JG. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007;14:14491457.

    • Search Google Scholar
    • Export Citation
  • 60

    Tam-McDevitt J. Polypharmacy, aging, and cancer. Oncology (Williston Park) 2008;22:10521055, discussion 1055, 1058, 1060.

  • 61

    Maggiore RJ, Gross CP, Hurria A. Polypharmacy in older adults with cancer. Oncologist 2010;15:507522.

  • 62

    Sokol KC, Knudsen JF, Li MM. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007;32:169175.

    • Search Google Scholar
    • Export Citation
  • 63

    Puts MT, Costa-Lima B, Monette J. Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study. Drugs Aging 2009;26:519536.

    • Search Google Scholar
    • Export Citation
  • 64

    Lees J, Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 2011;12:12491257.

  • 65

    Riechelmann RP, Saad ED. A systematic review on drug interactions in oncology. Cancer Invest 2006;24:704712.

  • 66

    Riechelmann RP, Tannock IF, Wang L. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007;99:592600.

    • Search Google Scholar
    • Export Citation
  • 67

    Riechelmann RP, Zimmermann C, Chin SN. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008;35:535543.

    • Search Google Scholar
    • Export Citation
  • 68

    Popa M, Wallace K, Brunello A, Extermann M. The impact of polypharmacy on toxicity from chemotherapy in elderly patients: focus on cytochrome P-450 inhibition and protein binding effects [abstract]. J Clin Oncol 2008;26(Suppl 15):Abstract 9505.

    • Search Google Scholar
    • Export Citation
  • 69

    Steinman MA, Landefeld SC, Rosenthal GE. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006;54:15161523.

  • 70

    Currow DC, Stevenson JP, Abernethy AP. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007;55:590595.

  • 71

    Maggiore RJ, Gross CP, Hardt M. Polypharmacy, potentially inappropriate medications, and chemotherapy-related adverse events among older adults with cancer [abstract]. J Clin Oncol 2011;29(Supp 1):Abstract e19501.

    • Search Google Scholar
    • Export Citation
  • 72

    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997;157:15311536.

    • Search Google Scholar
    • Export Citation
  • 73

    Fick DM, Cooper JW, Wade WE. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:27162724.

    • Search Google Scholar
    • Export Citation
  • 74

    Flood KL, Carroll MB, Le CV, Brown CJ. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother 2009;7:151158.

    • Search Google Scholar
    • Export Citation
  • 75

    Lichtman SM, Boparai MK. Geriatric medication management: evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (>=65 years) cancer patients [asbtract]. J Clin Oncol 2009;27(Suppl):Abstract 9507.

    • Search Google Scholar
    • Export Citation
  • 76

    Hanlon JT, Schmader KE, Samsa GP. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:10451051.

  • 77

    Samsa GP, Hanlon JT, Schmader KE. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994;47:891896.

    • Search Google Scholar
    • Export Citation
  • 78

    Schmader K, Hanlon JT, Weinberger M. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994;42:12411247.

    • Search Google Scholar
    • Export Citation
  • 79

    Kassam R, Martin LG, Farris KB. Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003;37:4046.

    • Search Google Scholar
    • Export Citation
  • 80

    Hanlon JT, Artz MB, Pieper CF. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004;38:914.

  • 81

    Gallagher P, Baeyens JP, Topinkova E. Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009;38:603606.

    • Search Google Scholar
    • Export Citation
  • 82

    Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing 2008;37:673679.

    • Search Google Scholar
    • Export Citation
  • 83

    Barry PJ, Gallagher P, Ryan C, O’Mahony D. START (screening tool to alert doctors to the right treatment)—an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007;36:632638.

    • Search Google Scholar
    • Export Citation
  • 84

    Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2011;89:845854.

    • Search Google Scholar
    • Export Citation
  • 85

    Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002;18:737757.

    • Search Google Scholar
    • Export Citation
  • 86

    Vellas B, Guigoz Y, Garry PJ. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999;15:116122.

    • Search Google Scholar
    • Export Citation
  • 87

    Rubenstein LZ, Harker JO, Salva A. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001;56:M366372.

    • Search Google Scholar
    • Export Citation
  • 88

    Bjorkman MP, Sorva AJ, Risteli J, Tilvis RS. Low parathyroid hormone levels in bedridden geriatric patients with vitamin D deficiency. J Am Geriatr Soc 2009;57:10451050.

    • Search Google Scholar
    • Export Citation
  • 89

    Stilley CS, Bender CM, Dunbar-Jacob J. The impact of cognitive function on medication management: three studies. Health Psychol 2010;29:5055.

    • Search Google Scholar
    • Export Citation
  • 90

    Extermann M. Older patients, cognitive impairment, and cancer: an increasingly frequent triad. J Natl Compr Canc Netw 2005;3:593596.

  • 91

    Chew ML, Mulsant BH, Pollock BG. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008;56:13331341.

    • Search Google Scholar
    • Export Citation
  • 92

    Hilmer SN, Mager DE, Simonsick EM. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007;167:781787.

    • Search Google Scholar
    • Export Citation
  • 93

    Naeim A, Reuben D. Geriatric syndromes and assessment in older cancer patients. Oncology (Williston Park) 2001;15:15671577.

  • 94

    Seeman TE, Kaplan GA, Knudsen L. Social network ties and mortality among the elderly in the Alameda County Study. Am J Epidemiol 1987;126:714723.

    • Search Google Scholar
    • Export Citation
  • 95

    Tomaka J, Thompson S, Palacios R. The relation of social isolation, loneliness, and social support to disease outcomes among the elderly. J Aging Health 2006;18:359384.

    • Search Google Scholar
    • Export Citation
  • 96

    Kroenke CH, Kubzansky LD, Schernhammer ES. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 2006;24:11051111.

    • Search Google Scholar
    • Export Citation
  • 97

    Flood KL, Carroll MB, Le CV. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol 2006;24:22982303.

    • Search Google Scholar
    • Export Citation
  • 98

    Mohile SG, Fan L, Reeve E. Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol 2011;29:14581464.

  • 99

    Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc 2004;52:16811687.

    • Search Google Scholar
    • Export Citation
  • 100

    Raji MA, Kuo YF, Freeman JL, Goodwin JS. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. Arch Intern Med 2008;168:20332040.

    • Search Google Scholar
    • Export Citation
  • 101

    Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:23862391.

    • Search Google Scholar
    • Export Citation
  • 102

    Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922935.

  • 103

    Kawas C, Karagiozis H, Resau L. Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol 1995;8:238242.

    • Search Google Scholar
    • Export Citation
  • 104

    Nasreddine ZS, Phillips NA, Bedirian V. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695699.

    • Search Google Scholar
    • Export Citation
  • 105

    Olson RA, Chhanabhai T, McKenzie M. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Support Care Cancer 2008;16:12731278.

    • Search Google Scholar
    • Export Citation
  • 106

    Olson RA, Iverson GL, Carolan H. Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life. J Neurooncol 2011;105:337344.

    • Search Google Scholar
    • Export Citation
  • 107

    Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:19341943.

    • Search Google Scholar
    • Export Citation
  • 108

    Kales HC, Valenstein M, Kim HM. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 2007;164:15681576; quiz 1623.

    • Search Google Scholar
    • Export Citation
  • 109

    Rochon PA, Normand SL, Gomes T. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008;168:10901096.

    • Search Google Scholar
    • Export Citation
  • 110

    Bush SH, Bruera E. The assessment and management of delirium in cancer patients. Oncologist 2009;14:10391049.

  • 111

    Inouye SK. Delirium in older persons. N Engl J Med 2006;354:11571165.

  • 112

    Inouye SK, van Dyck CH, Alessi CA. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990;113:941948.

    • Search Google Scholar
    • Export Citation
  • 113

    Wei LA, Fearing MA, Sternberg EJ, Inouye SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc 2008;56:823830.

    • Search Google Scholar
    • Export Citation
  • 114

    Lawlor PG, Nekolaichuk C, Gagnon B. Clinical utility, factor analysis, and further validation of the memorial delirium assessment scale in patients with advanced cancer: assessing delirium in advanced cancer. Cancer 2000;88:28592867.

    • Search Google Scholar
    • Export Citation
  • 115

    Gaudreau JD, Gagnon P, Harel F. Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage 2005;29:368375.

    • Search Google Scholar
    • Export Citation
  • 116

    Gaudreau JD, Gagnon P, Harel F. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005;23:67126718.

    • Search Google Scholar
    • Export Citation
  • 117

    Gaudreau JD, Gagnon P, Roy MA. Opioid medications and longitudinal risk of delirium in hospitalized cancer patients. Cancer 2007;109:23652373.

    • Search Google Scholar
    • Export Citation
  • 118

    Yesavage JA, Brink TL, Rose TL. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:3749.

    • Search Google Scholar
    • Export Citation
  • 119

    D’Ath P, Katona P, Mullan E. Screening, detection and management of depression in elderly primary care attenders. I: the acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract 1994;11:260266.

    • Search Google Scholar
    • Export Citation
  • 120

    Jongenelis K, Pot AM, Eisses AM. Diagnostic accuracy of the original 30-item and shortened versions of the Geriatric Depression Scale in nursing home patients. Int J Geriatr Psychiatry 2005;20:10671074.

    • Search Google Scholar
    • Export Citation
  • 121

    Jacobsen PB. Assessment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004:9397.

  • 122

    Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry 2003;8:229240.

    • Search Google Scholar
    • Export Citation
  • 123

    Respini D, Jacobsen PB, Thors C. The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 2003;47:273279.

  • 124

    Hurria A, Li D, Hansen K. Distress in older patients with cancer. J Clin Oncol 2009;27:43464351.

  • 125

    Zabora J, BrintzenhofeSzoc K, Jacobsen P. A new psychosocial screening instrument for use with cancer patients. Psychosomatics 2001;42:241246.

    • Search Google Scholar
    • Export Citation
  • 126

    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361370.

  • 127

    Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol 2007;25:46704681.

    • Search Google Scholar
    • Export Citation
  • 128

    Hoffman BM, Zevon MA, D’Arrigo MC, Cecchini TB. Screening for distress in cancer patients: the NCCN rapid-screening measure. Psychooncology 2004;13:792799.

    • Search Google Scholar
    • Export Citation
  • 129

    Jacobsen PB, Donovan KA, Trask PC. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005;103:14941502.

  • 130

    Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999;130:945950.

  • 131

    Fried LP, Tangen CM, Walston J. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146156.

  • 132

    Rao A, Cohen HJ. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr 2004:150157.

  • 133

    Minton O, Strasser F, Radbruch L, Stone P. Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European Palliative Care Research Collaborative computerized symptom assessment data set. J Pain Symptom Manage, in press.

    • Search Google Scholar
    • Export Citation
  • 134

    Demetri GD, Kris M, Wade J. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998;16:34123425.

    • Search Google Scholar
    • Export Citation
  • 135

    Vogelzang NJ, Breitbart W, Cella D. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34:412.

    • Search Google Scholar
    • Export Citation
  • 136

    Berger AM, Farr L. The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncol Nurs Forum 1999;26:16631671.

    • Search Google Scholar
    • Export Citation
  • 137

    Hardy SE, Studenski SA. Fatigue and function over 3 years among older adults. J Gerontol A Biol Sci Med Sci 2008;63:13891392.

  • 138

    Luciani A, Jacobsen PB, Extermann M. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol 2008;31:424430.

  • 139

    Rao SS. Prevention of falls in older patients. Am Fam Physician 2005;72:8188.

  • 140

    Stone C, Lawlor PG, Nolan B, Kenny RA. A prospective study of the incidence of falls in patients with advanced cancer. J Pain Symptom Manage 2011;42:535540.

    • Search Google Scholar
    • Export Citation
  • 141

    Chang JT, Morton SC, Rubenstein LZ. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 2004;328:680680.

    • Search Google Scholar
    • Export Citation
  • 142

    Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011;59:148157.

    • Search Google Scholar
    • Export Citation
  • 143

    Balducci L. Bone complications of cancer treatment in the elderly. Oncology (Williston Park) 2010;24:741747.

  • 144

    Gralow JR, Biermann JS, Farooki A. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw 2009;7(Suppl 3):S132; quiz S33–35.

    • Search Google Scholar
    • Export Citation
  • 145

    Sessums LL, Zembrzuska H, Jackson JL. Does this patient have medical decision-making capacity? JAMA 2011;306:420427.

  • 146

    Harrington SE, Smith TJ. The role of chemotherapy at the end of life: “when is enough, enough?” JAMA 2008;299:26672678.

  • 147

    Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am 2000;14:116.

  • 148

    Monfardini S, Ferrucci L, Fratino L. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996;77:395401.

    • Search Google Scholar
    • Export Citation
  • 149

    Ramesh H, Pope D, Gennari R, Audisio R. Optimising surgical management of elderly cancer patients. World J Surg Oncol 2005;3:17.

  • 150

    Audisio RA, Bozzetti F, Gennari R. The surgical management of elderly cancer patients; recommendations of the SIOG surgical task force. Eur J Cancer 2004;40:926938.

    • Search Google Scholar
    • Export Citation
  • 151

    Audisio RA, Ramesh H, Longo WE. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 2005;10:262268.

  • 152

    Pope D, Ramesh H, Gennari R. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol 2006;15:189197.

    • Search Google Scholar
    • Export Citation
  • 153

    Audisio RA, Pope D, Ramesh HS. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008;65:156163.

    • Search Google Scholar
    • Export Citation
  • 154

    Zachariah B, Balducci L. Radiation therapy of the older patient. Hematol Oncol Clin North Am 2000;14:131167.

  • 155

    Donato V, Valeriani M, Zurlo A. Short course radiation therapy for elderly cancer patients. Evidences from the literature review. Crit Rev Oncol Hematol 2003;45:305311.

    • Search Google Scholar
    • Export Citation
  • 156

    Mitsuhashi N, Hayakawa K, Yamakawa M. Cancer in patients aged 90 years or older: radiation therapy. Radiology 1999;211:829833.

  • 157

    Wasil T, Lichtman SM, Gupta V, Rush S. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000;23:526530.

  • 158

    Zachariah B, Balducci L, Venkattaramanabalaji GV. Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys 1997;39:11251129.

    • Search Google Scholar
    • Export Citation
  • 159

    Gelman RS, Taylor SG. Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncol 1984;2:14041413.

    • Search Google Scholar
    • Export Citation
  • 160

    Ibrahim NK, Frye DK, Buzdar AU. Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome. Arch Intern Med 1996;156:882888.

    • Search Google Scholar
    • Export Citation
  • 161

    Giovanazzi-Bannon S, Rademaker A, Lai G, Benson AB. Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol 1994;12:24472452.

    • Search Google Scholar
    • Export Citation
  • 162

    Newcomb PA, Carbone PP. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 1993;85:15801584.

  • 163

    Lichtman SM, Wildiers H, Chatelut E. International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients—an analysis of the medical literature. J Clin Oncol 2007;25:18321843.

    • Search Google Scholar
    • Export Citation
  • 164

    Balducci L, Corcoran MB. Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin North Am 2000;14:193212.

  • 165

    Hurria A, Lichtman SM. Clinical pharmacology of cancer therapies in older adults. Br J Cancer 2008;98:517522.

  • 166

    Extermann M, Bonetti M, Sledge GW. MAX2—a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer 2004;40:11931198.

    • Search Google Scholar
    • Export Citation
  • 167

    Shayne M, Crawford J, Dale DC. Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy. Breast Cancer Res Treat 2006;100:255262.

    • Search Google Scholar
    • Export Citation
  • 168

    Extermann M, Boler I, Reich R. The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: design and validation [abstract]. J Clin Oncol 2010;28(Suppl 15):Abstract 9000.

    • Search Google Scholar
    • Export Citation
  • 169

    Hurria A, Togawa K, Mohile SG. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 2011;29:34573465.

    • Search Google Scholar
    • Export Citation
  • 170

    Jelliffe RW, Jelliffe SM. Estimation of creatinine clearance from changing serum-creatinine levels. Lancet 1971;2:710.

  • 171

    Maloney KW, Kagan SH. Adherence and oral agents with older patients. Semin Oncol Nurs 2011;27:154160.

  • 172

    Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 2001;19:322328.

    • Search Google Scholar
    • Export Citation
  • 173

    Fink AK, Gurwitz J, Rakowski W. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor—positive breast cancer. J Clin Oncol 2004;22:33093315.

    • Search Google Scholar
    • Export Citation
  • 174

    Owusu C, Buist DS, Field TS. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol 2008;26:549555.

    • Search Google Scholar
    • Export Citation
  • 175

    Partridge AH, Archer L, Kornblith AB. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol 2010;28:24182422.

    • Search Google Scholar
    • Export Citation
  • 176

    Hershman DL, Shao T, Kushi LH. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011;126:529537.

    • Search Google Scholar
    • Export Citation
  • 177

    Floyd JD, Nguyen DT, Lobins RL. Cardiotoxicity of cancer therapy. J Clin Oncol 2005;23:76857696.

  • 178

    Hershman DL, McBride RB, Eisenberger A. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin’s lymphoma. J Clin Oncol 2008;26:31593165.

    • Search Google Scholar
    • Export Citation
  • 179

    Aapro M, Bernard-Marty C, Brain EGC. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol 2011;22:257267.

    • Search Google Scholar
    • Export Citation
  • 180

    Suter TM, Procter M, van Veldhuisen DJ. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 2007;25:38593865.

    • Search Google Scholar
    • Export Citation
  • 181

    Tan-Chiu E, Yothers G, Romond E. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. J Clin Oncol 2005;23:78117819.

    • Search Google Scholar
    • Export Citation
  • 182

    Perez EA, Suman VJ, Davidson NE. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol 2008;26:12311238.

    • Search Google Scholar
    • Export Citation
  • 183

    Procter M, Suter TM, de Azambuja E. Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. J Clin Oncol 2010;28:34223428.

    • Search Google Scholar
    • Export Citation
  • 184

    Russell SD, Blackwell KL, Lawrence J. Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trials. J Clin Oncol 2010;28:34163421.

    • Search Google Scholar
    • Export Citation
  • 185

    Serrano C, Cortes J, De Mattos-Arruda L. Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors. Ann Oncol, in press.

    • Search Google Scholar
    • Export Citation
  • 186

    Slamon D, Eiermann W, Robert N. Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in her2neu positive early breast cancer patients: BCIRG 006 study [abstract]. Presented at the 2009 San Antionio Breast Cancer Symposium; December 9–13, 2009; San Antonio, Texas. Abstract 62.

    • Search Google Scholar
    • Export Citation
  • 187

    Valero V, Forbes J, Pegram MD. Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active therapeutic regimens. J Clin Oncol 2011;29:149156.

    • Search Google Scholar
    • Export Citation
  • 188

    Jones S, Holmes FA, O’Shaughnessy J. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735. J Clin Oncol 2009;27:11771183.

    • Search Google Scholar
    • Export Citation
  • 189

    Swain SM, Whaley FS, Gerber MC. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy. J Clin Oncol 1997;15:13331340.

    • Search Google Scholar
    • Export Citation
  • 190

    Swain SM, Whaley FS, Gerber MC. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer. J Clin Oncol 1997;15:13181332.

    • Search Google Scholar
    • Export Citation
  • 191

    Marty M, Espie M, Llombart A. Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy. Ann Oncol 2006;17:614622.

    • Search Google Scholar
    • Export Citation
  • 192

    Launay-Vacher V, Chatelut E, Lichtman SM. Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations. Ann Oncol 2007;18:13141321.

    • Search Google Scholar
    • Export Citation
  • 193

    Sul JK, Deangelis LM. Neurologic complications of cancer chemotherapy. Semin Oncol 2006;33:324332.

  • 194

    Cheson BD, Vena DA, Foss FM, Sorensen JM. Neurotoxicity of purine analogs: a review. J Clin Oncol 1994;12:22162228.

  • 195

    Smith GA, Damon LE, Rugo HS. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol 1997;15:833839.

    • Search Google Scholar
    • Export Citation
  • 196

    Rubin EH, Andersen JW, Berg DT. Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia. J Clin Oncol 1992;10:948953.

    • Search Google Scholar
    • Export Citation
  • 197

    Balducci L, Repetto L. Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma. Cancer 2004;100:611.

  • 198

    Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983;52:19861992.

    • Search Google Scholar
    • Export Citation
  • 199

    Crivellari D. Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group. Tumori 2002;88(1 Suppl 1):S8182.

    • Search Google Scholar
    • Export Citation
  • 200

    Langer CJ, Manola J, Bernardo P. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002;94:173181.

    • Search Google Scholar
    • Export Citation
  • 201

    Rocha Lima CM, Herndon JE >II, Kosty M. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B. Cancer 2002;94:181187.

    • Search Google Scholar
    • Export Citation
  • 202

    Neubauer M, Schwartz J, Caracandas J. Results of a phase II study of weekly paclitaxel plus carboplatin in patients with extensive small-cell lung cancer with Eastern Cooperative Oncology Group performance status of 2, or age > or = 70 years. J Clin Oncol 2004;22:18721877.

    • Search Google Scholar
    • Export Citation
  • 203

    Doorduijn JK, van der Holt B, van Imhoff GW. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin’s lymphoma. J Clin Oncol 2003;21:30413050.

    • Search Google Scholar
    • Export Citation
  • 204

    Osby E, Hagberg H, Kvaloy S. CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial. Blood 2003;101:38403848.

    • Search Google Scholar
    • Export Citation
  • 205

    Zinzani PL, Pavone E, Storti S. Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin’s lymphoma. Blood 1997;89:39743979.

    • Search Google Scholar
    • Export Citation
  • 206

    Armitage JO, Potter JF. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly: increased complications with advancing age. J Am Geriatr Soc 1984;32:269273.

    • Search Google Scholar
    • Export Citation
  • 207

    Bastion Y, Blay JY, Divine M. Elderly patients with aggressive non-Hodgkin’s lymphoma: disease presentation, response to treatment, and survival—a Groupe d’Etude des Lymphomes de l’Adulte study on 453 patients older than 69 years. J Clin Oncol 1997;15:29452953.

    • Search Google Scholar
    • Export Citation
  • 208

    Bertini M, Freilone R, Vitolo U. The treatment of elderly patients with aggressive non-Hodgkin’s lymphomas: feasibility and efficacy of an intensive multidrug regimen. Leuk Lymphoma 1996;22:483493.

    • Search Google Scholar
    • Export Citation
  • 209

    Gomez H, Mas L, Casanova L. Elderly patients with aggressive non-Hodgkin’s lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity. J Clin Oncol 1998;16:23522358.

    • Search Google Scholar
    • Export Citation
  • 210

    O’Reilly SE, Connors JM, Howdle S. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy. J Clin Oncol 1993;11:22502257.

    • Search Google Scholar
    • Export Citation
  • 211

    Sonneveld P, de Ridder M, van der Lelie H. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin’s lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol 1995;13:25302539.

    • Search Google Scholar
    • Export Citation
  • 212

    Amadori S, Suciu S, Jehn U. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. Blood 2005;106:2734.

    • Search Google Scholar
    • Export Citation
  • 213

    Lowenberg B, van Putten W, Theobald M. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med 2003;349:743752.

    • Search Google Scholar
    • Export Citation
  • 214

    Lyman GH, Kuderer NM, Djulbegovic B. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med 2002;112:406411.

    • Search Google Scholar
    • Export Citation
  • 215

    Relling MV, Boyett JM, Blanco JG. Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment. Blood 2003;101:38623867.

    • Search Google Scholar
    • Export Citation
  • 216

    Patt DA, Duan Z, Fang S. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol 2007;25:38713876.

    • Search Google Scholar
    • Export Citation
  • 217

    Lyman GH, Kuderer N, Agboola O, Balducci L. Evidence-based use of colony-stimulating factors in elderly cancer patients. Cancer Control 2003;10:487499.

    • Search Google Scholar
    • Export Citation
  • 218

    Repetto L, Biganzoli L, Koehne CH. EORTC cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer. Eur J Cancer 2003;39:22642272.

    • Search Google Scholar
    • Export Citation
  • 219

    Pierelli L, Perillo A, Greggi S. Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. J Clin Oncol 1999;17:12881296.

    • Search Google Scholar
    • Export Citation
  • 220

    Metivier F, Marchais SJ, Guerin AP. Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant 2000;15(Suppl 3):1418.

    • Search Google Scholar
    • Export Citation
  • 221

    Pickett JL, Theberge DC, Brown WS. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis 1999;33:11221130.

  • 222

    Silverberg DS, Wexler D, Blum M. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:17371744.

    • Search Google Scholar
    • Export Citation
  • 223

    Wu WC, Rathore SS, Wang Y. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:12301236.

  • 224

    Bohlius J, Wilson J, Seidenfeld J. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 2006;98:708714.

    • Search Google Scholar
    • Export Citation
  • 225

    Juneja V, Keegan P, Gootenberg JE. Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer. Clin Cancer Res 2008;14:32423247.

    • Search Google Scholar
    • Export Citation
  • 226

    Bennett CL, Silver SM, Djulbegovic B. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008;299:914924.

    • Search Google Scholar
    • Export Citation
  • 227

    Tepler I, Elias L, Smith JW. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996;87:36073614.

    • Search Google Scholar
    • Export Citation
  • 228

    Vadhan-Raj S. Management of chemotherapy-induced thrombocytopenia: current status of thrombopoietic agents. Semin Hematol 2009;46:S2632.

    • Search Google Scholar
    • Export Citation
  • 229

    Benson AB, Ajani JA, Catalano RB. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004;22:29182926.

    • Search Google Scholar
    • Export Citation
  • 230

    Rubenstein EB, Peterson DE, Schubert M. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100:20262046.

    • Search Google Scholar
    • Export Citation
  • 231

    Bensinger W, Schubert M, Ang KK. NCCN Task Force Report: prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 2008;6(Suppl 1):121.

    • Search Google Scholar
    • Export Citation
  • 232

    Spielberger R, Stiff P, Bensinger W. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:25902598.

    • Search Google Scholar
    • Export Citation
  • 233

    Rosen LS, Abdi E, Davis ID. Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy. J Clin Oncol 2006;24:51945200.

    • Search Google Scholar
    • Export Citation
  • 234

    Peterson DE, Jones JB, Petit RG. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy. Cancer 2007;109:322331.

    • Search Google Scholar
    • Export Citation
  • 235

    Gonsalves W, Ganti AK. Targeted anti-cancer therapy in the elderly. Crit Rev Oncol Hematol 2011;78:227242.

  • 236

    Sekeres MA. Treatment of older adults with acute myeloid leukemia: state of the art and current perspectives. Haematologica 2008;93:17691772.

    • Search Google Scholar
    • Export Citation
  • 237

    Joudi FN, Smith BJ, O’Donnell MA, Konety BR. The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy. J Urol 2006;175:16341639.

    • Search Google Scholar
    • Export Citation
  • 238

    Herr HW. Age and outcome of superficial bladder cancer treated with bacille Calmette-Guerin therapy. Urology 2007;70:6568.

  • 239

    Chamie K, Hu B, Devere White RW, Ellison LM. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008;102:284290.

    • Search Google Scholar
    • Export Citation
  • 240

    Grossman HB, Natale RB, Tangen CM. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003;349:859866.

    • Search Google Scholar
    • Export Citation
  • 241

    Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000;92:550556.

    • Search Google Scholar
    • Export Citation
  • 242

    Eppenberger-Castori S, Moore DH Jr, Thor AD. Age-associated biomarker profiles of human breast cancer. Int J Biochem Cell Biol 2002;34:13181330.

    • Search Google Scholar
    • Export Citation
  • 243

    Bouchardy C, Rapiti E, Fioretta G. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003;21:35803587.

    • Search Google Scholar
    • Export Citation
  • 244

    Yood MU, Owusu C, Buist DSM. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 2008;206:6675.

  • 245

    Schonberg MA, Marcantonio ER, Li D. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 2010;28:20382045.

    • Search Google Scholar
    • Export Citation
  • 246

    Giuliano AE, Hunt KK, Ballman KV. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569575.

    • Search Google Scholar
    • Export Citation
  • 247

    Rudenstam CM, Zahrieh D, Forbes JF. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol 2006;24:337344.

    • Search Google Scholar
    • Export Citation
  • 248

    Martelli G, Miceli R, Daidone MG. Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol 2011;18:125133.

    • Search Google Scholar
    • Export Citation
  • 249

    Hughes KS, Schnaper LA, Berry D. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351:971977.

    • Search Google Scholar
    • Export Citation
  • 250

    Hughes KS, Schnaper LA, Cirrincione C. Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer [abstract]. J Clin Oncol 2010;28(Suppl 15):Abstract 507.

    • Search Google Scholar
    • Export Citation
  • 251

    Muss HB, Woolf S, Berry D. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 2005;293:10731081.

  • 252

    Muss HB, Berry DA, Cirrincione CT. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 2009;360:20552065.

  • 253

    Piccart-Gebhart MJ, Procter M, Leyland-Jones B. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:16591672.

    • Search Google Scholar
    • Export Citation
  • 254

    Romond EH, Perez EA, Bryant J. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005;353:16731684.

    • Search Google Scholar
    • Export Citation
  • 255

    Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J. Debulking or biopsy of malignant glioma in elderly people. A randomized study. Acta Neurochir 2003;145:510.

    • Search Google Scholar
    • Export Citation
  • 256

    Martinez R, Janka M, Soldner F, Behr R. Gross total resection of malignant glioma in elderly patients: implications in survival. Zentrabl Neurchir 2007;68:176181.

    • Search Google Scholar
    • Export Citation
  • 257

    Scott J, Suh J, Elson P. Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 2011;13:428436.

    • Search Google Scholar
    • Export Citation
  • 258

    Roa W, Brasher PM, Bauman G. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized trial. J Clin Oncol 2004;22:15831588.

    • Search Google Scholar
    • Export Citation
  • 259

    Keime-Guibert F, Chinot O, Taillandier L. Radiotherapy for glioblastoma in the elderly. N Engl J Med 2007;356:15271535.

  • 260

    Stupp R, Hegi M, Mason W. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459466.

    • Search Google Scholar
    • Export Citation
  • 261

    Lanzetta G, Minniti G. Treatment of glioblastoma in elderly patients: an overview of current treatments and future perspective. Tumori 2010;96:650658.

    • Search Google Scholar
    • Export Citation
  • 262

    Nghiemphu PL, Liu W, Lee Y. Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology 2009;72:12171222.

    • Search Google Scholar
    • Export Citation
  • 263

    Gavrilovic I, Hormigo A, Yahalom J. Long term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 2006;24:45704574.

    • Search Google Scholar
    • Export Citation
  • 264

    Ney DE, Reiner AS, Panageas KS. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer 2010;116:46054612.

    • Search Google Scholar
    • Export Citation
  • 265

    Zhu JJ, Gerstner ER, Engler DA. High-dose methotrexate for elderly patients with primary CNS lymphoma. Neuro Oncol 2009;11:211215.

  • 266

    Schiffmann L, Ozcan S, Schwarz F. Colorectal cancer in the elderly: surgical treatment and long-term survival. Int J Colorectal Dis 2008;23:601610.

    • Search Google Scholar
    • Export Citation
  • 267

    Devon KM, Vergara-Fernandez O, Victor JC, McLeod RS. Colorectal cancer surgery in elderly patients: presentation, treatment, and outcomes. Dis Colon Rectum 2009;52:12721277.

    • Search Google Scholar
    • Export Citation
  • 268

    Ong ES, Alassas M, Dunn KB, Rajput A. Colorectal cancer surgery in the elderly: acceptable morbidity? Am J Surg 2008;195:344348.

  • 269

    Adam R, Frilling A, Elias D. Liver resection of colorectal metastases in elderly patients. Br J Surg 2010;97:366376.

  • 270

    Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850857.

    • Search Google Scholar
    • Export Citation
  • 271

    Jackson McCleary NA, Meyerhardt J, Green E. Impact of older age on the efficacy of newer adjuvant therapies in >12,500 patients (pts) with stage II/III colon cancer: findings from the ACCENT Database. J Clin Oncol 2009;27:4010.

    • Search Google Scholar
    • Export Citation
  • 272

    Folprecht G, Cunningham D, Ross P. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann Oncol 2004;15:13301338.

    • Search Google Scholar
    • Export Citation
  • 273

    Seymour MT, Thompson LC, Wasan HS. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet 2011;377:17491759.

    • Search Google Scholar
    • Export Citation
  • 274

    Figer A, Perez-Staub N, Carola E. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 2007;110:26662671.

    • Search Google Scholar
    • Export Citation
  • 275

    Cassidy J, Saltz LB, Giantonio BJ. Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies. J Cancer Res Clin Oncol 2010;136:737743.

    • Search Google Scholar
    • Export Citation
  • 276

    Kozloff MF, Berlin J, Flynn PJ. Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study. Oncology 2010;78:329339.

    • Search Google Scholar
    • Export Citation
  • 277

    Bouchahda M, Macarulla T, Spano JP. Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancer. Crit Rev Oncol Hematol 2008;67:255262.

    • Search Google Scholar
    • Export Citation
  • 278

    Fornaro L, Baldi GG, Masi G. Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status. Crit Rev Oncol Hematol 2011;78:243251.

    • Search Google Scholar
    • Export Citation
  • 279

    Sastre J, Aranda E, Gravalos C. First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD). Crit Rev Oncol Hematol 2011;77:7884.

    • Search Google Scholar
    • Export Citation
  • 280

    Van Cutsem E, Peeters M, Siena S. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 2007;25:16581664.

    • Search Google Scholar
    • Export Citation
  • 281

    Amado RG, Wolf M, Peeters M. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:16261634.

    • Search Google Scholar
    • Export Citation
  • 282

    Zabrodsky M, Calabrese L, Tosoni A. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 2004;13:249255.

    • Search Google Scholar
    • Export Citation
  • 283

    Pignon